Literature DB >> 25565683

The role of untreated psychosis in neurodegeneration: a review of hypothesized mechanisms of neurotoxicity in first-episode psychosis.

Kelly K Anderson1, Aristotle Voineskos2, Benoit H Mulsant3, Tony P George4, Kwame J Mckenzie5.   

Abstract

For over 20 years, studies have tried to measure the association between the duration of untreated psychosis (DUP) and changes in brain morphology. A hypothesis that untreated psychosis is neurotoxic has been postulated, but the mechanisms of that toxicity have not been described. We re-analyzed papers collected for a systematic review to extract data on the hypotheses that have been generated on the potential mechanisms by which DUP could impact brain morphology in first-episode psychosis. Dopaminergic hyperactivity, prolonged hypothalamic-pituitary-adrenal activation, and persistent activity of catecholamines have been hypothesized as mechanisms to explain these associations. However, the question remains as to whether the observed structural changes are permanent or may be reversed via antipsychotic treatment.

Entities:  

Mesh:

Year:  2014        PMID: 25565683      PMCID: PMC4197784          DOI: 10.1177/070674371405901003

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  36 in total

1.  Volumetric MRI measurement of caudate nuclei in antipsychotic-naive patients suffering from a first episode of psychosis.

Authors:  Sitra Tauscher-Wisniewski; Johannes Tauscher; Bruce K Christensen; David J Mikulis; Robert B Zipursky
Journal:  J Psychiatr Res       Date:  2004-11-23       Impact factor: 4.791

Review 2.  Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.

Authors:  Diana O Perkins; Hongbin Gu; Kalina Boteva; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

Review 3.  Is active psychosis neurotoxic?

Authors:  T H McGlashan
Journal:  Schizophr Bull       Date:  2006-08-16       Impact factor: 9.306

4.  A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness.

Authors:  Lone Petersen; Pia Jeppesen; Anne Thorup; Maj-Britt Abel; Johan Øhlenschlaeger; Torben Østergaard Christensen; Gertrud Krarup; Per Jørgensen; Merete Nordentoft
Journal:  BMJ       Date:  2005-09-02

Review 5.  Neuroleptics and the natural course of schizophrenia.

Authors:  R J Wyatt
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

6.  Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs.

Authors:  M H Chakos; J A Lieberman; R M Bilder; M Borenstein; G Lerner; B Bogerts; H Wu; B Kinon; M Ashtari
Journal:  Am J Psychiatry       Date:  1994-10       Impact factor: 18.112

7.  Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible?

Authors:  M S Keshavan; G L Haas; C E Kahn; E Aguilar; E L Dick; N R Schooler; J A Sweeney; J W Pettegrew
Journal:  J Psychiatr Res       Date:  1998 May-Aug       Impact factor: 4.791

8.  Untreated illness duration correlates with gray matter loss in first-episode psychoses.

Authors:  Srihari S Bangalore; Dhruman D Goradia; Jeffrey Nutche; Vaibhav A Diwadkar; Konasale M R Prasad; Matcheri S Keshavan
Journal:  Neuroreport       Date:  2009-05-06       Impact factor: 1.837

Review 9.  Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.

Authors:  S Navari; P Dazzan
Journal:  Psychol Med       Date:  2009-04-02       Impact factor: 7.723

10.  Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

Authors:  P Fusar-Poli; R Smieskova; M J Kempton; B C Ho; N C Andreasen; S Borgwardt
Journal:  Neurosci Biobehav Rev       Date:  2013-06-14       Impact factor: 8.989

View more
  10 in total

1.  How does untreated psychosis lead to neurological damage?

Authors:  Kwame J Mckenzie
Journal:  Can J Psychiatry       Date:  2014-10       Impact factor: 4.356

Review 2.  Kraepelin revisited: schizophrenia from degeneration to failed regeneration.

Authors:  P Falkai; M J Rossner; T G Schulze; A Hasan; M M Brzózka; B Malchow; W G Honer; A Schmitt
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992

3.  Duration of Untreated Psychosis Correlates With Brain Connectivity and Morphology in Medication-Naïve Patients With First-Episode Psychosis.

Authors:  Jose O Maximo; Eric A Nelson; William P Armstrong; Nina V Kraguljac; Adrienne C Lahti
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-11-09

4.  Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study.

Authors:  Murat Beyazyüz; Tarkan Küfeciler; Leyla Bulut; Cüneyt Ünsal; Yakup Albayrak; Esra Soydaş Akyol; Saliha Baykal; Murat Kuloglu; Kenji Hashimoto
Journal:  Neuropsychiatr Dis Treat       Date:  2016-05-23       Impact factor: 2.570

5.  DNA Methylation Changes in Intron 1 of Triggering Receptor Expressed on Myeloid Cell 2 in Japanese Schizophrenia Subjects.

Authors:  Yuta Yoshino; Yuki Ozaki; Kiyohiro Yamazaki; Tomoko Sao; Yoko Mori; Shinichiro Ochi; Jun-Ichi Iga; Shu-Ichi Ueno
Journal:  Front Neurosci       Date:  2017-05-23       Impact factor: 4.677

6.  Early intervention services for non-psychotic mental health disorders: a scoping review protocol.

Authors:  Katie Richards; Amelia Austin; Karina Allen; Ulrike Schmidt
Journal:  BMJ Open       Date:  2019-12-05       Impact factor: 2.692

7.  Aripiprazole LAI two-injection start in a 16 year-old adolescent with schizophrenia.

Authors:  Virginio Salvi; Cristina Appignanesi; Brodinela Marpepa; Laura Orsolini; Umberto Volpe
Journal:  Neuropsychopharmacol Rep       Date:  2022-02-19

Review 8.  Adolescent Neurodevelopment and Vulnerability to Psychosis.

Authors:  Pooja K Patel; Logan D Leathem; Danielle L Currin; Katherine H Karlsgodt
Journal:  Biol Psychiatry       Date:  2020-07-10       Impact factor: 12.810

9.  A study in first-episode psychosis patients: does angiotensin I-converting enzyme (ACE) activity associated with genotype predict symptoms severity reductions after treatment with the atypical antipsychotic risperidone?

Authors:  João V Nani; Caroline Dal Mas; Camila M Yonamine; Vanessa K Ota; Cristiano Noto; Sintia I Belangero; Jair J Mari; Rodrigo Bressan; Quirino Cordeiro; Ary Gadelha; Mirian A F Hayashi
Journal:  Int J Neuropsychopharmacol       Date:  2020-07-22       Impact factor: 5.176

10.  White matter integrity, duration of untreated psychosis, and antipsychotic treatment response in medication-naïve first-episode psychosis patients.

Authors:  Nina Vanessa Kraguljac; Thomas Anthony; Charity Johanna Morgan; Ripu Daman Jindal; Mark Steven Burger; Adrienne Carol Lahti
Journal:  Mol Psychiatry       Date:  2020-05-12       Impact factor: 15.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.